ID   GhrasT-NIH/Swiss
AC   CVCL_WS34
DR   Wikidata; Q93561017
RX   PubMed=26254261;
CC   Transfected with: HGNC; 5173; HRAS (with p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=26254261; DOI=10.1016/j.yexcr.2015.07.029;
RA   Ray D.B., Merrill G.A., Brenner F.J., Lytle L.S., Lam T.,
RA   McElhinney A., Anders J., Rock T.T., Lyker J.K., Barcus S.,
RA   Leslie K.H., Kramer J.M., Rubenstein E.M., Pryor Schanz K.,
RA   Parkhurst A.J., Peck M., Good K., Granath K.L., Cifra N.,
RA   Detweiler J.W., Stevens L., Albertson R., Deir R., Stewart E.,
RA   Wingard K., Richardson M.R., Blizard S.B., Gillespie L.E.,
RA   Kriley C.E., Rzewnicki D.I., Jones D.H.;
RT   "T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial
RT   tumorigenic in vitro/in vivo passages give rise to increasingly
RT   aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell
RT   lines T3-HA and T4-PA.";
RL   Exp. Cell Res. 340:1-11(2016).
//